Published in J Infect Dis on April 01, 1990
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1992) 3.10
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother (1992) 2.68
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol (1992) 2.36
In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrob Agents Chemother (1992) 2.12
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol (1997) 2.08
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest (1999) 1.94
In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents. Antimicrob Agents Chemother (1993) 1.82
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax (1996) 1.78
Chlamydia pneumoniae and asthma. Thorax (1998) 1.67
Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol (1993) 1.63
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob Agents Chemother (1998) 1.60
Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol (1997) 1.55
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother (1994) 1.55
Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother (1994) 1.49
Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol (1996) 1.49
Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax (1996) 1.48
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev (2002) 1.45
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol (1995) 1.45
Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol (1997) 1.41
Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae. Infect Immun (1991) 1.40
Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis (1994) 1.37
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob Agents Chemother (1994) 1.32
Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol (2000) 1.30
A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun (1993) 1.29
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J Clin Microbiol (1994) 1.22
Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog. Infect Immun (1991) 1.21
Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun (1992) 1.19
Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev (1994) 1.19
Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol (1991) 1.19
Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J Clin Microbiol (2002) 1.18
Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun (2000) 1.18
The transcriptional landscape of Chlamydia pneumoniae. Genome Biol (2011) 1.16
Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol (1994) 1.15
Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia. J Clin Microbiol (1999) 1.14
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrob Agents Chemother (1995) 1.12
De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun (1999) 1.09
Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. J Clin Microbiol (2007) 1.08
A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1. Cell Microbiol (2009) 1.07
In vitro activity of trovafloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother (1997) 1.07
Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol. J Clin Microbiol (1991) 1.07
Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun (1993) 1.04
Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol (1995) 1.04
Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae. J Clin Microbiol (1998) 1.02
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother (1997) 1.02
Selective translocation of annexins during intracellular redistribution of Chlamydia trachomatis in HeLa and McCoy cells. Infect Immun (1994) 1.00
Evolutionary relationships among members of the genus Chlamydia based on 16S ribosomal DNA analysis. J Bacteriol (1997) 1.00
Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays. Clin Diagn Lab Immunol (2000) 0.99
Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol (2002) 0.97
Differentiation of Chlamydia spp. by sequence determination and restriction endonuclease cleavage of RNase P RNA genes. J Clin Microbiol (1996) 0.97
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. Antimicrob Agents Chemother (1998) 0.94
Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun (2001) 0.94
Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol (1996) 0.94
Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection. Clin Diagn Lab Immunol (1997) 0.93
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res (2008) 0.93
Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin Diagn Lab Immunol (2002) 0.93
Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations. J Clin Microbiol (1999) 0.92
Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun (2002) 0.91
Limits of the microimmunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis. Clin Diagn Lab Immunol (1996) 0.91
Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope. Infect Immun (1994) 0.90
Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun (2001) 0.90
Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol (1993) 0.89
Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1992) 0.89
Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax (2005) 0.89
Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell. J Bacteriol (2013) 0.89
Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials (2006) 0.88
Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture. J Clin Microbiol (1994) 0.88
Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. Thorax (1993) 0.88
Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis (2001) 0.86
Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies. Clin Diagn Lab Immunol (2002) 0.85
Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun (2005) 0.85
Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens. J Clin Microbiol (2006) 0.85
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice. Antimicrob Agents Chemother (1994) 0.85
Mutagenesis and functional reconstitution of chlamydial major outer membrane proteins: VS4 domains are not required for pore formation but modify channel function. Infect Immun (2001) 0.84
Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae. Antimicrob Agents Chemother (2003) 0.84
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. Antimicrob Agents Chemother (1996) 0.84
Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. Clin Diagn Lab Immunol (1999) 0.84
Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol (2005) 0.84
Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol (2004) 0.83
In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun (1997) 0.83
Sudden psychotic episode probably due to meningoencephalitis and Chlamydia pneumoniae acute infection. Clin Pract Epidemiol Ment Health (2005) 0.82
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur J Clin Microbiol Infect Dis (2003) 0.82
Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls. PLoS One (2009) 0.81
Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol (1998) 0.81
Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother (2002) 0.80
Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol (2002) 0.80
Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae. BMC Genomics (2012) 0.80
High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect (1995) 0.80
The Role of Chlamydia in Upper Respiratory Tract Infections. Curr Infect Dis Rep (2000) 0.80
Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J Clin Microbiol (1999) 0.80
Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol (2007) 0.80
In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae. Antimicrob Agents Chemother (1999) 0.80
Association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex. Thorax (2006) 0.78
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol (2012) 0.78
Chlamydia pneumoniae infection in polarized epithelial cell lines. Infect Immun (2010) 0.78
Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis. Open Neurol J (2008) 0.78
The origin of major human infections and the crucial role of person-to-person spread. Epidemiol Infect (1991) 0.77
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science (1987) 4.59
Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J Abnorm Psychol (2001) 4.53
Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol (2001) 4.30
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax (2001) 3.72
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38
Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol (2001) 3.36
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J (1978) 3.33
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Fatal air embolism during dental implant surgery: a report of three cases. Can J Anaesth (1990) 3.04
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Hysterectomy and urinary incontinence: a systematic review. Lancet (2000) 2.89
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Compulsory community and involuntary outpatient treatment for people with severe mental disorders. Cochrane Database Syst Rev (2005) 2.50
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48
Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation (1994) 2.24
Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10
Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr (1993) 2.10
Cross-reactivity between Chlamydiazyme and Acinetobacter strains. N Engl J Med (1986) 2.09
Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg (2001) 2.08
Immunologic classification of Neisseria gonorrhoeae with micro-immunofluorescence. J Immunol (1977) 2.08
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand (1981) 2.03
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae. Infect Immun (1987) 1.98
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br J Vener Dis (1978) 1.97
Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96